المؤلفون: Lofiego MF; University of Siena, Siena, Italy., Piazzini F; University of Siena, Siena, Italy., Caruso FP; BIOGEM Institute of Molecular Biology and Genetics, Ariano Irpino, Italy.; Department of Electrical Engineering and Information Technology (DIETI), University of Naples 'Federico II', Naples, Italy., Marzani F; University of Siena, Siena, Italy., Solmonese L; Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy., Bello E; University of Siena, Siena, Italy., Celesti F; University of Siena, Siena, Italy., Costa MC; BIOGEM Institute of Molecular Biology and Genetics, Ariano Irpino, Italy.; Department of Electrical Engineering and Information Technology (DIETI), University of Naples 'Federico II', Naples, Italy., Noviello T; BIOGEM Institute of Molecular Biology and Genetics, Ariano Irpino, Italy.; Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL, USA.; Department of Public Health Sciences, Miller School of Medicine, University of Miami, Miami, FL, USA., Mortarini R; Human Tumors Immunobiology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Anichini A; Human Tumors Immunobiology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Ceccarelli M; BIOGEM Institute of Molecular Biology and Genetics, Ariano Irpino, Italy.; Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL, USA.; Department of Public Health Sciences, Miller School of Medicine, University of Miami, Miami, FL, USA., Coral S; University of Siena, Siena, Italy., Di Giacomo AM; University of Siena, Siena, Italy.; Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy., Maio M; University of Siena, Siena, Italy.; Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy., Covre A; University of Siena, Siena, Italy. alessia.covre2@unisi.it.

مؤلفون مشاركون: EPigenetic Immune-oncology Consortium Airc (EPICA) investigators

المصدر: Journal of translational medicine [J Transl Med] 2024 Mar 01; Vol. 22 (1), pp. 223. Date of Electronic Publication: 2024 Mar 01.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876 (Electronic) Linking ISSN: 14795876 NLM ISO Abbreviation: J Transl Med Subsets: MEDLINE

مواضيع طبية MeSH: Glioblastoma*/genetics , Glioblastoma*/therapy , Glioblastoma*/metabolism, Azacitidine/*analogs & derivatives, Humans ; Azacitidine/therapeutic use ; Epigenesis, Genetic ; Immunotherapy

المؤلفون: Calabrò L; Department of Translational Medicine, University of Ferrara, Ferrara, Italy.; Department of Oncology, University Hospital of Ferrara, Ferrara, Italy., Bronte G; Department of Clinical and Molecular Sciences (DISCLIMO), Università Politecnica Delle Marche, Ancona, Italy.; Clinic of Laboratory and Precision Medicine, National Institute of Health and Sciences On Ageing (IRCCS INRCA), Ancona, Italy., Grosso F; Mesothelioma, Melanoma and Sarcoma Unit, Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy., Cerbone L; Mesothelioma, Melanoma and Sarcoma Unit, Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy., Delmonte A; Department of Medical Oncology, IRCCS Istituto Romagnolo Per Lo Studio Dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Nicolini F; IRCCS Istituto Romagnolo Per Lo Studio Dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Mazza M; IRCCS Istituto Romagnolo Per Lo Studio Dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Di Giacomo AM; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Siena, Italy.; Center for Immuno-Oncology, University of Siena, Siena, Italy., Covre A; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Siena, Italy.; Center for Immuno-Oncology, University of Siena, Siena, Italy.; EPigenetic Immune-Oncology Consortium Airc (EPICA), Siena, Italy., Lofiego MF; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Siena, Italy.; Center for Immuno-Oncology, University of Siena, Siena, Italy.; EPigenetic Immune-Oncology Consortium Airc (EPICA), Siena, Italy., Crinò L; Department of Medical Oncology, IRCCS Istituto Romagnolo Per Lo Studio Dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Maio M; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Siena, Italy.; Center for Immuno-Oncology, University of Siena, Siena, Italy.; EPigenetic Immune-Oncology Consortium Airc (EPICA), Siena, Italy.; Fondazione Network Italiano per la Bioterapia dei Tumori (NIBIT) Onlus, Siena, Italy.

المصدر: Frontiers in immunology [Front Immunol] 2024 Jan 08; Vol. 14, pp. 1333661. Date of Electronic Publication: 2024 Jan 08 (Print Publication: 2023).

نوع المنشور: Journal Article; Review; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Mesothelioma*/drug therapy , Mesothelioma, Malignant* , Pleural Neoplasms*, Humans ; Immunotherapy ; Pemetrexed

المؤلفون: Noviello TMR; Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL, USA.; BIOGEM Institute of Molecular Biology and Genetics, Ariano Irpino, Italy., Di Giacomo AM; University of Siena, Siena, Italy.; Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy.; NIBIT Foundation Onlus, Siena, Italy., Caruso FP; BIOGEM Institute of Molecular Biology and Genetics, Ariano Irpino, Italy.; Department of Electrical Engineering and Information Technology (DIETI), University of Naples 'Federico II', Naples, Italy., Covre A; University of Siena, Siena, Italy., Mortarini R; Human Tumors Immunobiology Unit, Dept. of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Scala G; Department of Biology, University of Naples 'Federico II', Naples, Italy., Costa MC; BIOGEM Institute of Molecular Biology and Genetics, Ariano Irpino, Italy.; Department of Electrical Engineering and Information Technology (DIETI), University of Naples 'Federico II', Naples, Italy., Coral S; University of Siena, Siena, Italy., Fridman WH; INSERM, UMR_S 1138, Centre de Recherche des Cordeliers, Team Cancer, Immune Control and Escape, Paris, France.; University Paris Descartes Paris 5, Sorbonne Paris Cite, UMR_S 1138, Centre de Recherche des Cordeliers, Paris, France.; Sorbonne University, UMR_S 1138, Centre de Recherche des Cordeliers, Paris, France., Sautès-Fridman C; INSERM, UMR_S 1138, Centre de Recherche des Cordeliers, Team Cancer, Immune Control and Escape, Paris, France.; University Paris Descartes Paris 5, Sorbonne Paris Cite, UMR_S 1138, Centre de Recherche des Cordeliers, Paris, France.; Sorbonne University, UMR_S 1138, Centre de Recherche des Cordeliers, Paris, France., Brich S; Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Pruneri G; Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Simonetti E; Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy., Lofiego MF; University of Siena, Siena, Italy., Tufano R; BIOGEM Institute of Molecular Biology and Genetics, Ariano Irpino, Italy.; Department of Science and Technology, University of Sannio, Benevento, Italy., Bedognetti D; Cancer Program, Human Immunology Department, Research Branch, Sidra Medicine, Doha, Qatar.; Department of Internal Medicine, University of Genoa, Genoa, Italy., Anichini A; Human Tumors Immunobiology Unit, Dept. of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Maio M; University of Siena, Siena, Italy. maio@unisi.it.; Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy. maio@unisi.it.; NIBIT Foundation Onlus, Siena, Italy. maio@unisi.it., Ceccarelli M; Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL, USA.; Department of Public Health Sciences, Miller School of Medicine, University of Miami, Miami, FL, USA.

المصدر: Nature communications [Nat Commun] 2023 Sep 22; Vol. 14 (1), pp. 5914. Date of Electronic Publication: 2023 Sep 22.

نوع المنشور: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

مواضيع طبية MeSH: Multiomics* , Melanoma*/drug therapy , Melanoma*/genetics, Humans ; Ipilimumab/therapeutic use ; Follow-Up Studies

المؤلفون: Anichini A; Human Tumors Immunobiology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy. andrea.anichini@istitutotumori.mi.it., Molla A; Human Tumors Immunobiology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy., Nicolini G; Human Tumors Immunobiology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy., Perotti VE; Human Tumors Immunobiology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy., Sgambelluri F; Human Tumors Immunobiology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy., Covre A; Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy.; University of Siena, Siena, Italy., Fazio C; Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy., Lofiego MF; Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy., Di Giacomo AM; Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy.; University of Siena, Siena, Italy., Coral S; Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy., Manca A; Unit of Cancer Genetics, National Research Council (CNR), Sassari, Italy., Sini MC; Unit of Cancer Genetics, National Research Council (CNR), Sassari, Italy., Pisano M; Unit of Cancer Genetics, National Research Council (CNR), Sassari, Italy., Noviello T; Department of Electrical Engineering and Information Technology (DIETI), University of Naples 'Federico II', Naples, Italy.; BIOGEM Institute of Molecular Biology and Genetics, Ariano Irpino, Italy., Caruso F; Department of Electrical Engineering and Information Technology (DIETI), University of Naples 'Federico II', Naples, Italy.; BIOGEM Institute of Molecular Biology and Genetics, Ariano Irpino, Italy., Brich S; Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Pruneri G; Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; University of Milan, School of Medicine, Milan, Italy., Maurichi A; Melanoma and Sarcoma Unit, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Santinami M; Melanoma and Sarcoma Unit, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Ceccarelli M; Department of Electrical Engineering and Information Technology (DIETI), University of Naples 'Federico II', Naples, Italy.; BIOGEM Institute of Molecular Biology and Genetics, Ariano Irpino, Italy., Palmieri G; Unit of Cancer Genetics, National Research Council (CNR), Sassari, Italy.; University of Sassari, Sassari, Italy., Maio M; Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy.; University of Siena, Siena, Italy., Mortarini R; Human Tumors Immunobiology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy.

مؤلفون مشاركون: EPigenetic Immune-oncology Consortium AIRC (EPICA) investigators

المصدر: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2022 Nov 17; Vol. 41 (1), pp. 325. Date of Electronic Publication: 2022 Nov 17.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 8308647 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-9966 (Electronic) Linking ISSN: 03929078 NLM ISO Abbreviation: J Exp Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Melanoma*/drug therapy , Melanoma*/genetics , Melanoma*/pathology , Skin Neoplasms*/genetics, Humans ; Ipilimumab/therapeutic use ; Immunotherapy ; Epigenesis, Genetic

المؤلفون: Di Giacomo AM; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Siena, Italy; University of Siena, Siena, Italy; Italian Network for Tumor Bio-Immunotherapy Foundation Onlus, Italy., Giacobini G; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Siena, Italy., Anichini G; Virology Unit, Department of Medical Biotechnologies, University of Siena, Siena, Italy., Gandolfo C; Virology Unit, Department of Medical Biotechnologies, University of Siena, Siena, Italy., D'alonzo V; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Siena, Italy; University of Siena, Siena, Italy., Calabrò L; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Siena, Italy., Lofiego MF; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Siena, Italy., Cusi MG; Virology Unit, Department of Medical Biotechnologies, University of Siena, Siena, Italy., Maio M; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Siena, Italy; University of Siena, Siena, Italy; Italian Network for Tumor Bio-Immunotherapy Foundation Onlus, Italy. Electronic address: maio@unisi.it.

المصدر: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 Aug; Vol. 171, pp. 143-149. Date of Electronic Publication: 2022 May 25.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19*/prevention & control , COVID-19 Vaccines*/adverse effects , Neoplasms*/therapy, Antibodies, Neutralizing ; Antibodies, Viral ; Humans ; Immunoglobulin G ; SARS-CoV-2 ; Vaccines, Synthetic ; Viral Envelope Proteins/genetics ; mRNA Vaccines

SCR Organism: SARS-CoV-2 variants

المؤلفون: Lofiego MF; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, 53100 Siena, Italy.; Epigen Therapeutics S.R.L., 53100 Siena, Italy., Cannito S; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, 53100 Siena, Italy.; Medical Oncology, Department of Molecular and Developmental Medicine, University of Siena, 53100 Siena, Italy., Fazio C; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, 53100 Siena, Italy., Piazzini F; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, 53100 Siena, Italy., Cutaia O; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, 53100 Siena, Italy., Solmonese L; Epigen Therapeutics S.R.L., 53100 Siena, Italy.; Medical Oncology, Department of Molecular and Developmental Medicine, University of Siena, 53100 Siena, Italy., Marzani F; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, 53100 Siena, Italy., Chiarucci C; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, 53100 Siena, Italy., Di Giacomo AM; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, 53100 Siena, Italy.; Medical Oncology, Department of Molecular and Developmental Medicine, University of Siena, 53100 Siena, Italy., Calabrò L; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, 53100 Siena, Italy., Coral S; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, 53100 Siena, Italy.; Epigen Therapeutics S.R.L., 53100 Siena, Italy., Maio M; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, 53100 Siena, Italy.; Medical Oncology, Department of Molecular and Developmental Medicine, University of Siena, 53100 Siena, Italy., Covre A; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, 53100 Siena, Italy.; Medical Oncology, Department of Molecular and Developmental Medicine, University of Siena, 53100 Siena, Italy., On Behalf Of The EPigenetic Immune-Oncology Consortium Airc Epica Investigators

المصدر: Epigenomes [Epigenomes] 2021 Dec 14; Vol. 5 (4). Date of Electronic Publication: 2021 Dec 14.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101736595 Publication Model: Electronic Cited Medium: Internet ISSN: 2075-4655 (Electronic) Linking ISSN: 20754655 NLM ISO Abbreviation: Epigenomes Subsets: PubMed not MEDLINE

المؤلفون: Di Giacomo AM; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Siena, Italy., Giacobini G; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Siena, Italy., Gandolfo C; University of Siena, Siena, Italy., Lofiego MF; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Siena, Italy., Cusi MG; University of Siena, Siena, Italy., Maio M; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Siena, Italy; University of Siena, Siena, Italy; Italian Network for Tumor Bio-Immunotherapy Foundation Onlus, Italy. Electronic address: maio@unisi.it.

المصدر: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2021 Oct; Vol. 156, pp. 119-121. Date of Electronic Publication: 2021 Aug 05.

نوع المنشور: Letter

بيانات الدورية: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19/*prevention & control , COVID-19 Vaccines/*therapeutic use , Neoplasms/*therapy , SARS-CoV-2/*immunology, Antibodies, Viral/blood ; Antineoplastic Agents, Immunological/administration & dosage ; Antineoplastic Agents, Immunological/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; COVID-19/diagnosis ; COVID-19 Vaccines/immunology ; Case-Control Studies ; Drug Interactions ; Humans ; Immune Checkpoint Inhibitors/therapeutic use ; Immunogenicity, Vaccine/physiology ; Italy ; Neoplasms/blood ; Neoplasms/diagnosis ; Neoplasms/immunology ; Prognosis ; Prospective Studies ; Time Factors ; Treatment Outcome ; Vaccination/adverse effects ; Vaccination/statistics & numerical data

المؤلفون: Chiarucci C; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, 53100 Siena, Italy., Cannito S; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, 53100 Siena, Italy., Daffinà MG; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, 53100 Siena, Italy., Amato G; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, 53100 Siena, Italy., Giacobini G; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, 53100 Siena, Italy., Cutaia O; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, 53100 Siena, Italy., Lofiego MF; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, 53100 Siena, Italy., Fazio C; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, 53100 Siena, Italy., Giannarelli D; Unit of statistics, Regina Elena National Cancer Institute IRCCS, 00144 Rome, Italy., Danielli R; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, 53100 Siena, Italy., Di Giacomo AM; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, 53100 Siena, Italy., Coral S; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, 53100 Siena, Italy., Calabrò L; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, 53100 Siena, Italy., Maio M; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, 53100 Siena, Italy., Covre A; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, 53100 Siena, Italy.

المصدر: Cancers [Cancers (Basel)] 2020 Feb 05; Vol. 12 (2). Date of Electronic Publication: 2020 Feb 05.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

المؤلفون: Di Giacomo AM; Department of Oncology, Center for Immuno-Oncology, Medical Oncology and Immunotherapy, University Hospital of Siena, Viale Bracci, 14, 53100, Siena, Italy., Valente M; Department of Oncology, Center for Immuno-Oncology, Medical Oncology and Immunotherapy, University Hospital of Siena, Viale Bracci, 14, 53100, Siena, Italy., Cerase A; Unit of Neuroradiology, University Hospital, Siena, Italy., Lofiego MF; Department of Oncology, Center for Immuno-Oncology, Medical Oncology and Immunotherapy, University Hospital of Siena, Viale Bracci, 14, 53100, Siena, Italy., Piazzini F; Department of Oncology, Center for Immuno-Oncology, Medical Oncology and Immunotherapy, University Hospital of Siena, Viale Bracci, 14, 53100, Siena, Italy., Calabrò L; Department of Oncology, Center for Immuno-Oncology, Medical Oncology and Immunotherapy, University Hospital of Siena, Viale Bracci, 14, 53100, Siena, Italy., Gambale E; Department of Oncology, Center for Immuno-Oncology, Medical Oncology and Immunotherapy, University Hospital of Siena, Viale Bracci, 14, 53100, Siena, Italy., Covre A; Department of Oncology, Center for Immuno-Oncology, Medical Oncology and Immunotherapy, University Hospital of Siena, Viale Bracci, 14, 53100, Siena, Italy., Maio M; Department of Oncology, Center for Immuno-Oncology, Medical Oncology and Immunotherapy, University Hospital of Siena, Viale Bracci, 14, 53100, Siena, Italy. mmaiocro@gmail.com.

المصدر: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2019 Oct 17; Vol. 38 (1), pp. 419. Date of Electronic Publication: 2019 Oct 17.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 8308647 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-9966 (Electronic) Linking ISSN: 03929078 NLM ISO Abbreviation: J Exp Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Immunotherapy*/adverse effects, Antibodies, Monoclonal/*therapeutic use , Antineoplastic Agents, Immunological/*therapeutic use , Brain Neoplasms/*secondary , Brain Neoplasms/*therapy, Antibodies, Monoclonal/adverse effects ; Antineoplastic Agents, Immunological/adverse effects ; Brain Neoplasms/immunology ; CTLA-4 Antigen/antagonists & inhibitors ; CTLA-4 Antigen/immunology ; Carcinoma, Renal Cell/pathology ; Humans ; Kidney Neoplasms/pathology ; Lung Neoplasms/pathology ; Melanoma/pathology ; Programmed Cell Death 1 Receptor/antagonists & inhibitors ; Programmed Cell Death 1 Receptor/immunology

المؤلفون: Maio M; Italian Network for Tumor Bio-immunotherapy (NIBIT), Siena, Italy. mmaiocro@gmail.com.; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, V.le Bracci, 16, Siena, Italy. mmaiocro@gmail.com., Lofiego MF; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, V.le Bracci, 16, Siena, Italy., Fazio C; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, V.le Bracci, 16, Siena, Italy., Cannito S; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, V.le Bracci, 16, Siena, Italy.; University of Siena, Siena, Italy., Chiarucci C; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, V.le Bracci, 16, Siena, Italy., Giacobini G; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, V.le Bracci, 16, Siena, Italy., Valente M; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, V.le Bracci, 16, Siena, Italy., Tunici P; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, V.le Bracci, 16, Siena, Italy., Covre A; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, V.le Bracci, 16, Siena, Italy., Russo V; Italian Network for Tumor Bio-immunotherapy (NIBIT), Siena, Italy.; Immuno-biotherapy of Melanoma and Solid Tumors Unit, Division of Experimental Oncology, San Raffaele Hospital Scientific Institute, Milan, Italy.

المصدر: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2019 Jan; Vol. 68 (1), pp. 151-158. Date of Electronic Publication: 2018 Aug 09.

نوع المنشور: Congress

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE

مواضيع طبية MeSH: Biological Therapy/*methods , Immunotherapy/*methods , Medical Oncology/*methods , Neoplasms/*therapy, Humans ; Information Services/organization & administration ; Italy ; Medical Oncology/organization & administration ; Neoplasms/immunology ; Tumor Microenvironment/immunology